Sfoglia per Rivista HAEMATOLOGICA
Factor X Shanghai: a mutation disrupting translocation to the endoplasmic reticulum
2005-01-01 Asselta, R
Factor XI deficiency: identification and molecular characterization of six novel missense mutations
2006-01-01 Spena, S; Duga, S; Asselta, R; Ghiotto, R; Tagliaferri, A; Malcovati, M; Tenchini, Ml; Castaman, G
Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bbeta-chain gene
2006-01-01 Monaldini, L; Asselta, R; Duga, S; Peyvandi, F; Ghosh, K; Malcovati, M; Tenchini, Ml
Five new point mutations in fibrinogen alpha-chain gene causing afibrinogenemia
2000-01-01 Asselta, R; Duga, S; Malcovati, M; Simonic, T; Santagostino, E; Mannucci, Pm; Tenchini, Ml
Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms
2011-01-01 Elena, C; Rumi, E; Portolan, M; Della Porta, M; Pascutto, C; Passamonti, F.
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.
2009-01-01 Ongaro, A; De Mattei, M; Rigolin, G; Ambrosio, C; Di Raimondo, F; Pellati, A; Masieri, Ff; Caruso, A; Catozzi, L; Gemmati, D.; DELLA PORTA, MATTEO GIOVANNI
Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
2008-01-01 DELLA PORTA, MATTEO GIOVANNI
GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) PREVENTS DOSE-LIMITING NEUTROPENIA IN LYMPHOMA PATIENTS RECEIVING STANDARD-DOSE CHEMOTHERAPY
1995-01-01 Dotti, G; CARLO-STELLA, C.; Mangoni, L; Cottafavi, L; Caramatti, C; Almici, C; Rizzoli, V
Hematologic responses with deferasirox therapy in transfusion-dependent myelodysplastic syndromes patients.
2012-01-01 Gattermann, N.; Finelli, C.; Fenaux, P.; Stadler, M.; Guerci-Bresler, A.; Schmid, M.; Taylor, K.; Vassilieff, D.; Habr, D.; Marcellari, A.; Roubert, B.; Rose, C.; Della Porta, M. G.
Hemostatic alterations in COVID-19
2021-01-01 Peyvandi, Flora; Artoni, Andrea; Novembrino, Cristina; Aliberti, Stefano; Panigada, Mauro; Boscarino, Marco; Gualtierotti, Roberta; Rossi, Federica; Palla, Roberta; Martinelli, Ida; Grasselli, Giacomo; Blasi, Francesco; Tripodi, Armando
HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL SUBFRACTIONATION USING COUNTERFLOW CENTRIFUGATION ELUTRIATION
1991-01-01 Almici, C; Mangoni, L; CARLO-STELLA, C.; Rizzoli, V
Identification of six novel mutations causing coagulation factor V deficiency
2006-01-01 Dall’Osso, C; Asselta, R; Duga, S; Locatelli, N; Peyvandi, F; Skurzak, S; Malcovati, M; Tenchini, Ml
Ifosfamide, gemcitabine, and vinorelbine: a now induction regimen for refractory and relapsed Hodgkin's lymphoma
2007-01-01 Santoro, A; Magagnoli, M; Spina, M; Pinotti, G; Siracusano, L; Michieli, M; Nozza, A; Sarina, B; Morenghi, E; Castagna, L; Tirelli, U; Balzarotti, M
IL-1R8, A NEGATIVE REGULATOR OF INFLAMMATION AND CHECKPOINT MOLECULE
2018-01-01 Garlanda, C
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.
2017-01-01 Westers, Tm; Cremers, Em; Oelschlaegel, U; Johansson, U; Bettelheim, P; Matarraz, S; Orfao, A; Moshaver, B; Brodersen, Le; Loken, Mr; Wells, Da; Subirá, D; Cullen, M; Te Marvelde, Jg; van der Velden, Vh; Preijers, Fw; Chu, Sc; Feuillard, J; Guérin, E; Psarra, K; Porwit, A; Saft, L; Ireland, R; Milne, T; Béné, Mc; Witte, Bi; Della Porta, M; Kern, W; van de Loosdrecht, Aa
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
2011-01-01 DELLA PORTA, MATTEO GIOVANNI
IN VITRO GROWTH OF BONE MARROW-DERIVED MULTIPOTENT AND LINEAGE-RESTRICTED HEMATOPOIETIC PROGENITOR CELLS IN MYELODYSPLASTIC SYNDROMES
1989-01-01 CARLO STELLA, C.; Cazzola, M; Bernasconi, P; Bergamaschi, G; Dezza, L; Pedrazzoli, P; Rosti, V; Tomaselli, S; Zappone, E
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1
2013-01-01 DELLA PORTA, MATTEO GIOVANNI
INTERFERONS AS BIOLOGIC MODULATORS OF HEMATOPOIETIC-CELL PROLIFERATION AND DIFFERENTIATION
1988-01-01 CARLO STELLA, C.; Cazzola, M
INVITRO AND INVIVO EFFECTS OF RECOMBINANT INTERFERON GAMMA ON THE GROWTH OF HEMATOPOIETIC PROGENITOR CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME
1989-01-01 Rosti, V; CARLO-STELLA, C.; Pedrazzoli, P; Cazzola, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Factor X Shanghai: a mutation disrupting translocation to the endoplasmic reticulum | 1-gen-2005 | Asselta, R | |
| Factor XI deficiency: identification and molecular characterization of six novel missense mutations | 1-gen-2006 | Spena, S; Duga, S; Asselta, R; Ghiotto, R; Tagliaferri, A; Malcovati, M; Tenchini, Ml; Castaman, G | |
| Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bbeta-chain gene | 1-gen-2006 | Monaldini, L; Asselta, R; Duga, S; Peyvandi, F; Ghosh, K; Malcovati, M; Tenchini, Ml | |
| Five new point mutations in fibrinogen alpha-chain gene causing afibrinogenemia | 1-gen-2000 | Asselta, R; Duga, S; Malcovati, M; Simonic, T; Santagostino, E; Mannucci, Pm; Tenchini, Ml | |
| Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms | 1-gen-2011 | Elena, C; Rumi, E; Portolan, M; Della Porta, M; Pascutto, C; Passamonti, F. | |
| Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival. | 1-gen-2009 | Ongaro, A; De Mattei, M; Rigolin, G; Ambrosio, C; Di Raimondo, F; Pellati, A; Masieri, Ff; Caruso, A; Catozzi, L; Gemmati, D.; DELLA PORTA, MATTEO GIOVANNI | |
| Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays. | 1-gen-2008 | DELLA PORTA, MATTEO GIOVANNI | |
| GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) PREVENTS DOSE-LIMITING NEUTROPENIA IN LYMPHOMA PATIENTS RECEIVING STANDARD-DOSE CHEMOTHERAPY | 1-gen-1995 | Dotti, G; CARLO-STELLA, C.; Mangoni, L; Cottafavi, L; Caramatti, C; Almici, C; Rizzoli, V | |
| Hematologic responses with deferasirox therapy in transfusion-dependent myelodysplastic syndromes patients. | 1-gen-2012 | Gattermann, N.; Finelli, C.; Fenaux, P.; Stadler, M.; Guerci-Bresler, A.; Schmid, M.; Taylor, K.; Vassilieff, D.; Habr, D.; Marcellari, A.; Roubert, B.; Rose, C.; Della Porta, M. G. | |
| Hemostatic alterations in COVID-19 | 1-gen-2021 | Peyvandi, Flora; Artoni, Andrea; Novembrino, Cristina; Aliberti, Stefano; Panigada, Mauro; Boscarino, Marco; Gualtierotti, Roberta; Rossi, Federica; Palla, Roberta; Martinelli, Ida; Grasselli, Giacomo; Blasi, Francesco; Tripodi, Armando | |
| HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL SUBFRACTIONATION USING COUNTERFLOW CENTRIFUGATION ELUTRIATION | 1-gen-1991 | Almici, C; Mangoni, L; CARLO-STELLA, C.; Rizzoli, V | |
| Identification of six novel mutations causing coagulation factor V deficiency | 1-gen-2006 | Dall’Osso, C; Asselta, R; Duga, S; Locatelli, N; Peyvandi, F; Skurzak, S; Malcovati, M; Tenchini, Ml | |
| Ifosfamide, gemcitabine, and vinorelbine: a now induction regimen for refractory and relapsed Hodgkin's lymphoma | 1-gen-2007 | Santoro, A; Magagnoli, M; Spina, M; Pinotti, G; Siracusano, L; Michieli, M; Nozza, A; Sarina, B; Morenghi, E; Castagna, L; Tirelli, U; Balzarotti, M | |
| IL-1R8, A NEGATIVE REGULATOR OF INFLAMMATION AND CHECKPOINT MOLECULE | 1-gen-2018 | Garlanda, C | |
| Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group. | 1-gen-2017 | Westers, Tm; Cremers, Em; Oelschlaegel, U; Johansson, U; Bettelheim, P; Matarraz, S; Orfao, A; Moshaver, B; Brodersen, Le; Loken, Mr; Wells, Da; Subirá, D; Cullen, M; Te Marvelde, Jg; van der Velden, Vh; Preijers, Fw; Chu, Sc; Feuillard, J; Guérin, E; Psarra, K; Porwit, A; Saft, L; Ireland, R; Milne, T; Béné, Mc; Witte, Bi; Della Porta, M; Kern, W; van de Loosdrecht, Aa | |
| Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS) | 1-gen-2011 | DELLA PORTA, MATTEO GIOVANNI | |
| IN VITRO GROWTH OF BONE MARROW-DERIVED MULTIPOTENT AND LINEAGE-RESTRICTED HEMATOPOIETIC PROGENITOR CELLS IN MYELODYSPLASTIC SYNDROMES | 1-gen-1989 | CARLO STELLA, C.; Cazzola, M; Bernasconi, P; Bergamaschi, G; Dezza, L; Pedrazzoli, P; Rosti, V; Tomaselli, S; Zappone, E | |
| Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1 | 1-gen-2013 | DELLA PORTA, MATTEO GIOVANNI | |
| INTERFERONS AS BIOLOGIC MODULATORS OF HEMATOPOIETIC-CELL PROLIFERATION AND DIFFERENTIATION | 1-gen-1988 | CARLO STELLA, C.; Cazzola, M | |
| INVITRO AND INVIVO EFFECTS OF RECOMBINANT INTERFERON GAMMA ON THE GROWTH OF HEMATOPOIETIC PROGENITOR CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME | 1-gen-1989 | Rosti, V; CARLO-STELLA, C.; Pedrazzoli, P; Cazzola, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile